FDA advisory group rejects Pacira’s pitch for expanded use of pain drug
A group of experts organized by the FDA has voted 6 to 4 against a move by Pacira Pharmaceuticals to get an approval to use …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
